Subway: 'Yoga mat chemical' almost out of bread
NEW YORK — Subway says an ingredient dubbed the “yoga mat chemical” will be entirely phased out of its bread by next week.
Subway has suffered from an onslaught of bad publicity since a food blogger petitioned the chain to remove the ingredient.
The ingredient, azodicarbonamide, is approved by the Food and Drug Administration for use in food as a bleaching agent and dough conditioner. It can be found in a variety of products, including those served at McDonald's, Burger King and Starbucks and breads sold in supermarkets. But its unfamiliar name has an unappetizing ring, and the petition became a flashpoint by noting that the chemical also is used to make yoga mats and isn't approved for use in some other parts of the world.
Tony Pace, Subway's chief marketing officer, said the chain started phasing out the ingredient late last year and that the process should be complete within a week. Subway is privately held and doesn't disclose its sales figures. But it is apparently feeling pressure from the uproar.
“You see the social media traffic, and people are happy that we're taking it out, but they want to know when we're taking it out,” Pace said. “If there are people who have that hesitation, that hesitation is going to be removed.”
The issue illustrates a split in thought about what should go into our food. One side says such additives are used in hundreds of food products and are safe to eat in the quantities approved by the FDA. The other side asks why such ingredients need to be used at all.
John Coupland, a professor of food science at Penn State University, noted that people concerned about azodicarbonamide focus in part on a carcinogen called urethane it creates in the baking process. But he said some level of urethane is already present in bread and that even toasting can increase its levels.
“Nobody worries about making toast,” Coupland said, adding that one could argue there's some type of risk associated with any number of chemicals.
Coupland questioned whether Subway's removal of the ingredient would make people think the food is healthier.
Subway, which has about 26,600 locations across the country, had said after the petition surfaced in February that it was in the process of removing the ingredient. But the company wouldn't provide details on a timeline, prompting some to say that the chain didn't really have a plan to remove the ingredient.
Pace stressed the removal isn't a reaction to the petition. The company provided a statement saying it tested the “Azo-free bread” in four markets this past fall.
It did not provide details on what changes it made to its bread to remove the ingredient.
“We're always trying to improve stuff,” Pace said. For instance, he noted that the chain has reduced sodium levels over the years and removed high-fructose corn syrup from its bread.
The blogger who created the Subway petition, Vani Hari of FoodBabe.com, said she targeted Subway because of its healthy food image. Hari said she was happy to hear about Subway's move but that the chain still had other questionable ingredients, such as caramel coloring and yeast extract.
“The entire point of the petition was that I wanted people to know that eating fresh is not really eating fresh,” she said.
Regardless of the safety of various ingredients, more people are looking to stick to diets they feel are natural. The trend has prompted numerous food makers to adjust their recipes, even as they stand by the safety of their products.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- ‘Word people’ could start careers as court reporters, medical scribes
- Small stores take big gamble by not upgrading credit card readers
- Stop neighbors from stealing your Internet
- Amazon raises bar for other retailers with same-day delivery
- Yahoo investors losing patience with ‘star’ CEO Marissa Mayer
- Shopping beacons join list of ‘next big thing’ disappointments
- Many Black Friday deals not worth the hassle
- Nutritional supplement makers, led by GNC, want to create voluntary safety standards
- Covestro leader MacCleary finds stability amid change
- Pfizer acquires Allergan in $160B deal
- Stocks finish flat before Thanksgiving holiday; energy firms give back some gains